Isaac S. AshkenaziIsaac S.Ashkenazi

Obtained an ITC victory for Viking Therapeutics in a trade secret misappropriation case brought against Chinese entities involved in a failed collaboration for a small molecule drug product for the treatment of NASH.

Prevailed in an arbitration for Daiichi Sankyo regarding a hotly-contested patent dispute and complex litigation, concerning rights to biotechnology which the drug maker uses for its cancer medicines.

Secured a favorable settlement on behalf of Alkermes following a five-day bench trial in a patent infringement action involving its Vivitrol® medication for alcohol and opioid dependence.

Successfully defended Mitsubishi Tanabe Pharma Corp.’s patent covering its blockbuster type 2 diabetes treatments, Invokana® and Invokamet®, in the first Hatch-Waxman Zoom trial in the District of New Jersey.

Obtained a claim construction ruling on appeal that eviscerated the University of Massachusetts’ and Carmel Laboratories’ infringement theory for all 130 L’Oréal USA products accused of infringement.

Secured favorable settlements on behalf of Adamas Pharmaceuticals, Inc. with first filers in patent infringement actions involving its Gocovri® Parkinson’s medication.

Obtained a favorable settlement on behalf of Boehringer Ingelheim in connection with patent challenges relating to its proposed biosimilar version of Humira®.

Obtained walkaways from six separate generics for Boehringer Ingelheim in Hatch-Waxman litigations involving its blockbuster Pradaxa® stroke medication.

Successfully defended Sunovion Inc.’s patent covering its popular sleep aid, Lunesta®, in one of the largest Hatch-Waxman Act litigations.

Obtained favorable settlements on behalf of Allos Therapeutics, Inc., with multiple defendants seeking approval for generic versions of its Folotyn® cancer treatment.

Represented Amgen Inc. in a patent infringement case concerning a modified growth colony-stimulating factor (G-CSF) for the treatment of neutropenia, and secured a complete walkaway in a patent infringement case brought by Teva concerning Amgen’s Sensipar® product, used for the treatment of secondary hyperparathyroidism.

Served as trial counsel for Pfizer Inc. (Wyeth) and Nycomed in a successful jury trial concerning a validity challenge to the patent covering the companies’ $2 billion-dollar-per-year acid reflux medication, Protonix®.

Managing Intellectual Property (2023)

The Legal 500''s Intellectual Property - Patents: Litigation (Full Coverage) (2021, 2023)

Law360, Rising Star in Life Sciences, 2018 -- for several high-stakes wins, including invalidating a key patent for Humira®, the world’s best-selling drug

The Legal 500 for two successful IPR petitions resulting in rulings that method-of-treatment claims covering the drug product Humira® would have been obvious

American Lawyer, Transatlantic IP Team of the Year, 2018 -- for leading a major pharmaceutical litigation through fact, expert and Markman phases, and obtaining six walk-away consent judgments

Law360 (2017)

Law360